Videos Library
What impact will the explosion in wearable and biosensors technologies have on the MedTech commercial landscape?
Related topics:
MedTech, Commercial, Global (non-specific), Digital & Technology
Overview
- Leveraging digital technology to achieve patient-centric outcomes & inform product development.
- Transition from sick-care to health-care and the technology convergence enabling this change.
- Technological and strategic approaches enabling the use of consumer & patient data in R&D.
Panelists
Arne Faisst
CEO
anfass Life Technologies AG, Switzerland
Rogier Keemink
Technical Product Manager
dacadoo, Switzerland
Ivana Schnur
Co-founder, CMO
Sense.ly, UK
Adam Yeung
Analytics Manager, Marketing Diabetes Care - Europe and EMA
BD, Switzerland
Igor Menghini
Director Market Intelligence
Roche Sequencing, UK
REMINDER
This is the presenters’ personal opinion and does not necessarily represent true facts, the official views or policy of their organisation, nor the views of Evidence Life Science.